| Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage … A Gallamini, M Hutchings, L Rigacci, L Specht, F Merli, M Hansen, C Patti, ... Journal of clinical oncology 25 (24), 3746-3752, 2007 | 1027 | 2007 |
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 859 | 2009 |
| Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study A Gallamini, C Stelitano, R Calvi, M Bellei, D Mattei, U Vitolo, F Morabito, ... Blood 103 (7), 2474-2479, 2004 | 764 | 2004 |
| High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, ... The Lancet 374 (9700), 1512-1520, 2009 | 714 | 2009 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 547 | 2020 |
| Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi … A Gallamini, F Zaja, C Patti, A Billio, MR Specchia, A Tucci, A Levis, ... Blood, The Journal of the American Society of Hematology 110 (7), 2316-2323, 2007 | 392 | 2007 |
| The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease A Gallamini, L Rigacci, F Merli, L Nassi, A Bosi, I Capodanno, S Luminari, ... haematologica 91 (4), 475-481, 2006 | 369 | 2006 |
| R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana … M Federico, S Luminari, A Dondi, A Tucci, U Vitolo, L Rigacci, ... Journal of Clinical Oncology 31 (12), 1506-1513, 2013 | 320 | 2013 |
| The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ... Haematologica 99 (6), 1107, 2014 | 290 | 2014 |
| Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP P Pregno, A Chiappella, M Bellò, B Botto, S Ferrero, S Franceschetti, ... Blood, The Journal of the American Society of Hematology 119 (9), 2066-2073, 2012 | 284 | 2012 |
| Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases M Federico, U Vitolo, PL Zinzani, T Chisesi, V Clo, G Bellesi, M Magagnoli, ... Blood, The Journal of the American Society of Hematology 95 (3), 783-789, 2000 | 233 | 2000 |
| [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the … M Martelli, L Ceriani, E Zucca, PL Zinzani, AJM Ferreri, U Vitolo, ... Journal of clinical oncology 32 (17), 1769-1775, 2014 | 189 | 2014 |
| Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection L Arcaini, C Besson, M Frigeni, H Fontaine, M Goldaniga, M Casato, ... Blood, The Journal of the American Society of Hematology 128 (21), 2527-2532, 2016 | 180 | 2016 |
| Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi L Arcaini, D Vallisa, S Rattotti, VV Ferretti, AJM Ferreri, P Bernuzzi, ... Annals of Oncology 25 (7), 1404-1410, 2014 | 173 | 2014 |
| Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma L Ceriani, M Martelli, PL Zinzani, AJM Ferreri, B Botto, C Stelitano, M Gotti, ... Blood, The Journal of the American Society of Hematology 126 (8), 950-956, 2015 | 172 | 2015 |
| Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter … A Tucci, M Martelli, L Rigacci, P Riccomagno, MG Cabras, F Salvi, ... Leukemia & lymphoma 56 (4), 921-926, 2015 | 159 | 2015 |
| Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients PL Zinzani, L Rigacci, V Stefoni, A Broccoli, B Puccini, A Castagnoli, ... European journal of nuclear medicine and molecular imaging 39, 4-12, 2012 | 156 | 2012 |
| Interim positron emission tomography response-adapted therapy in advanced-stage Hodgkin lymphoma: final results of the phase II part of the HD0801 study PL Zinzani, A Broccoli, DM Gioia, A Castagnoli, G Ciccone, A Evangelista, ... Journal of clinical oncology 34 (12), 1376-1385, 2016 | 155 | 2016 |
| Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final … A Chiappella, M Martelli, E Angelucci, E Brusamolino, A Evangelista, ... The Lancet Oncology 18 (8), 1076-1088, 2017 | 145 | 2017 |
| Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi C Visco, A Chiappella, L Nassi, C Patti, S Ferrero, D Barbero, ... The Lancet Haematology 4 (1), e15-e23, 2017 | 144 | 2017 |
